[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-339347-105":59,"doc-detail-339347-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","enhancement-of-therapeutic-potential-of-oncolytic-virus-with-homologous-tumor-cell-membranes-for-pancreatic-cancer","Enhancement of Therapeutic Potential of Oncolytic Virus with Homologous Tumor Cell Membranes for Pancreatic Cancer","","Pancreatic cancer causes a high global mortality burden, and conventional surgery, radiotherapy, and chemotherapy often deliver limited efficacy with notable side effects. Oncolytic viruses can selectively replicate in and kill tumor cells while sparing normal cells, but clinical translation is constrained by inefficient tumor infection, limited stability in vivo, and challenges in effective delivery through immune clearance and poor tumor penetration. A cell membrane-coated oncolytic virus was developed to enhance infectivity and killing. This study evaluates whether homologous tumor cell membranes and nonhomologous membranes produce comparable functional effects and finds improved antitumor activity with homologous membranes.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/enhancement-of-therapeutic-potential-of-oncolytic-virus-with-homologous-tumor-cell-membranes-for-pancreatic-cancer/339347/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/enhancement-of-therapeutic-potential-of-oncolytic-virus-with-homologous-tumor-cell-membranes-for-pancreatic-cancer/339347.png","ImageObject",300,407,{"name":92,"@type":93},"Eliana","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why are new treatment strategies needed for pancreatic cancer?","Question",{"text":112,"@type":113},"Conventional therapies show limited efficacy and significant side effects, while pancreatic cancer remains highly lethal worldwide.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What major obstacles limit oncolytic virus use in clinical settings?",{"text":117,"@type":113},"Oncolytic viruses face issues including insufficient tumor cell targeting/infection, instability in the body, and delivery failure due to immune clearance and limited tumor penetration.",{"name":119,"@type":110,"acceptedAnswer":120},"How does coating oncolytic viruses with tumor cell membranes aim to improve therapy?",{"text":121,"@type":113},"Membrane coating is used to mask viral characteristics, reduce immunogenicity, extend survival, evade immune clearance, and enhance targeting and antitumor activity; the study also examines homologous versus nonhomologous membrane effects.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},339347,1790211946,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":24,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},4398048949847,"https://ap-avatar.wpscdn.com/avatar/400002536579ef2da7f?_k=1778318612642679267","Hindawi  \nIET Nanobiotechnology  \nVolume 2024, Article ID 9970665, 5 pages [https://doi.org/10.1049/2024/9970665](https://doi.org/10.1049/2024/9970665)  \nResearch Article  \nEnhancement of Therapeutic Potential of Oncolytic Virus with Homologous Tumor Cell Membranes for Pancreatic Cancer  \nWei Chen , 1 Hui Liu ,2,3 Yue Chen ,4 and Meng Gao 1  \n1Department of Gastroenterology, The Second People ’s Hospital of Hefei, Hefei Hospital Afﬁliated to Anhui Medical University, Hefei, 230011, China  \n2Department of Gastroenterology, The Second People ’s Hospital of Hefei Afﬁliated to Bengbu Medical College, Hefei 230011, China 3Department of Gastroenterology, The Second People ’s Hospital of Hefei, Hefei 230011, China  \n4School of Clinical Medicine, Anhui Medical University, Hefei 230011, China  \nCorrespondence should be addressed to Yue Chen; 19530711806@163.com and Meng Gao; [gmahmueducation@163.com](gmahmueducation@163.com)  \nReceived 17 November 2023; Revised 21 January 2024; Accepted 5 February 2024; Published 13 February 2024  \nAcademic Editor: Abhimanyu Thakur  \nCopyright © 2024 Wei Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.  \nPancreatic cancer is a leading cause of cancer-related deaths worldwide. Conventional therapies often provide limited success, necessitating the need for novel therapeutic strategies. Oncolytic viruses (OVs) are a class of viruses that speciﬁcally target and kill cancer cells while leaving normal cells unharmed. These viruses have shown promise in the treatment of various cancers, including pancreatic cancer. However, their use in clinical settings has been limited by several factors. Their inability to efﬁciently infect and kill tumor cells. To overcome this limitation, a cell membrane-coated oncolytic virus was developed. However, the necessity of homologous and nonhomologous tumor cell membranes for their function has not yet been proven. This novel virus displayed increased infectivity and killing activity against tumor cells compared to nonhomologous tumor cell membranes and noncoated viruses. We believe that the homologous tumor cell membranes-coated OVs can enhance the therapeutic potential for pancreatic cancer therapy.  \n1. Introduction  \nPancreatic cancer remains a signiﬁcant health care challenge with a high rate of mortality worldwide [1–4] . Conventional treatment methods, such as surgery, radiotherapy, and chemotherapy, have shown limited efﬁcacy and signiﬁcant side effects. Therefore, the search for novel and more effective treatment strategies is crucial. Oncolytic viruses (OVs), which are viruses capable of speciﬁcally replicating in and killing tumor cells while sparing normal cells, have emerged as a potential new approach for the treatment of pancreatic cancer [5–7]. However, these viruses also face a number of challenges.  \nOVs have shown great potential in targeting and killing pancreatic cancer cells. This is due to the unique biological characteristics of tumor cells that render them susceptible to virus infection [8, 9] . For example, some pancreatic cancer cells express high levels of epidermal growth factor receptor (EGFR), which can be targeted by some OVs. By binding to EGFR, these viruses are able to speciﬁcally infect and kill  \npancreatic cancer cells [10, 11] . However, the use of OVsin pancreatic cancer treatment is also facing a number ofchallenges. First, not all pancreatic cancer cells can be targeted by these viruses, limiting their therapeutic effect [12] . Second, the stability of OVs in the body is also a concern [13] . Finally, the effective delivery of these viruses to the tumor site remains a challenge due to potential clearance by the immune system or limited penetration into the tumor [14–17] . The systemic delivery of OVs remains a major challenge in clinical treatment. The viruses","cbCaij1rcn9hBwtE","https://ap.wps.com/l/cbCaij1rcn9hBwtE","pdf",208396,"English","# Introduction\n## Background and limitations of current therapies\n## Challenges and rationale for oncolytic viruses\n# IET Nanobiotechnology\n## Tumor cell membranes for immune evasion and targeting\n## Delivery strategies and related approaches\n## Study aim and comparison of homologous vs nonhomologous membranes","[{\"question\":\"Why are new treatment strategies needed for pancreatic cancer?\",\"answer\":\"Conventional therapies show limited efficacy and significant side effects, while pancreatic cancer remains highly lethal worldwide.\"},{\"question\":\"What major obstacles limit oncolytic virus use in clinical settings?\",\"answer\":\"Oncolytic viruses face issues including insufficient tumor cell targeting/infection, instability in the body, and delivery failure due to immune clearance and limited tumor penetration.\"},{\"question\":\"How does coating oncolytic viruses with tumor cell membranes aim to improve therapy?\",\"answer\":\"Membrane coating is used to mask viral characteristics, reduce immunogenicity, extend survival, evade immune clearance, and enhance targeting and antitumor activity; the study also examines homologous versus nonhomologous membrane effects.\"}]","Enhancement of Therapeutic Potential of Oncolytic Virus with Homologous Tumor Cell Membranes for Pancreatic Cancer | PDF",1790029748,13,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d48b05a53df3599742e414093fe244f3.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/79c1ce0cab8167be102de757db790f38.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/938b3199953ed765528ab35a6c286c8a.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fc58d2be349f45c3d8b0e7d40f6801b5.webp",980,1306]